[CAS NO. 1257213-50-5] BMS-986020
Please click "REQUEST A QUOTE" button if you need other sizes or
custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis,
please:
PRODUCTS SPECIFICATIONS [1257213-50-5]
Catalog
SLK-S3572
Brand
Selleck
CAS
1257213-50-5
DESCRIPTION [1257213-50-5]
Overview
| MDL | MFCD30489743 |
|---|---|
| Molecular Weight | 482.53 |
| Molecular Formula | C29H26N2O5 |
| SMILES | - |
For research use only.
Storage
3 years,-20°C,powder
1 years,-80°C,in solvent
1 years,-80°C,in solvent
Shipping
Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)
Preparing Stock Solutions
| 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.0724 mL | 10.3621 mL | 20.7241 mL |
| 5 mM | 0.4145 mL | 2.0724 mL | 4.1448 mL |
| 10 mM | 0.2072 mL | 1.0362 mL | 2.0724 mL |
| 50 mM | 0.0414 mL | 0.2072 mL | 0.4145 mL |
Description
BMS-986020 (AM152, AP-3152 free acid) is a potent and selective antagonist of . BMS-986020 inhibits bile acid and phospholipid transporters with IC50 of 4.8 μM, 6.2 μM, and 7.5 μM for BSEP, MRP4, and MDR3, respectively. BMS-986020 has the potential for the treatment of idiopathic pulmonary fibrosis (IPF).
Targets
In vitro
BMS-986020, a selective and potent lysophosphatidic acid receptor 1 (LPA1) inhibitor, inhibits LPA1-induced fibrogenesis in the Scar-in-a-Jar in vitro model
References
Powered by Arctom Copyright © 2025 Arctom.
All rights reserved.